Neoadjuvant chemoradiotherapy followed by liver transplantation for unresectable cholangiocarcinoma: A single-centre national experience

HPB

Volumn 16, Issue 1, 2014, Pages 91-98

  Duignan, Sophie ^a   Maguire, Donal ^a   Ravichand, Chamarajanagar S ^a   Geoghegan, Justin ^a   Hoti, Emir ^a   Fennelly, David ^a   Armstrong, John ^a   Rock, Kathy ^a   Mohan, Helen ^a   Traynor, Oscar ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

CAPECITABINE; FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BRACHYTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; HUMAN TISSUE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MORTALITY; PILOT STUDY; PROGRESSION FREE SURVIVAL;

ADULT; AGED; ANTIMETABOLITES, ANTINEOPLASTIC; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; BRACHYTHERAPY; CA-19-9 ANTIGEN; CHEMORADIOTHERAPY, ADJUVANT; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; HOSPITAL MORTALITY; HUMANS; IRELAND; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; PILOT PROJECTS; PROGRAM EVALUATION; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84890550592     PISSN: 1365182X     EISSN: 14772574     Source Type: Journal    
DOI: 10.1111/hpb.12082     Document Type: Article

References (23)

1. Klatskin G,. (1965) Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 38: 241-256.
2. Blechacz B, Gores GJ,. (2008) Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology 48: 308-321. (Pubitemid 351975555)
3. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH,. (1998) Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 228: 385-394. (Pubitemid 30191701)
4. Pandey D, Lee KH, Tan KC,. (2007) The role of liver transplantation for hilar cholangiocarcinoma. Hepatobiliary Pancreat Dis Int 6: 248-253. (Pubitemid 46925244)
5. van der Gaag NA, Kloek JJ, de, Bakker JK, Musters B, Geskus RB, Busch OR, et al. (2012) Survival analysis and prognostic nomogram for patients undergoing resection of extrahepatic cholangiocarcinoma. Ann Oncol 23: 2642-2649.
6. Silva MA, Tekin K, Aytekin F, Bramhall SR, Buckels JA, Mirza DF,. (2005) Surgery for hilar cholangiocarcinoma; a 10 year experience of a tertiary referral centre in the K. Eur J Surg Oncol 31: 533-539. (Pubitemid 40724095)
7. De Vreede I, Steers JL, Burch PA, Rosen CB, Gunderson LL, Haddock MG, et al. (2000) Prolonged disease-free survival after orthotopic liver transplantation plus adjuvant chemoirradiation for cholangiocarcinoma. Liver Transpl 6: 309-316. (Pubitemid 30317226)
8. Sudan D, DeRoover A, Chinnakotla S, Fox I, Shaw B Jr, McCashland T, et al. (2002) Radiochemotherapy and transplantation allow long-term survival for nonresectable hilar cholangiocarcinoma. Am J Transplant 2: 774-779. (Pubitemid 36342621)
9. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, et al. (2004) Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 24: 201-207. (Pubitemid 38738348)
10. Heimbach JK, Gores GJ, Haddock MG, Alberts SR, Pedersen R, Kremers W, et al. (2006) Predictors of disease recurrence following neoadjuvant chemoradiotherapy and liver transplantation for unresectable perihilar cholangiocarcinoma. Transplantation 82: 1703-1707. (Pubitemid 46035655)
11. Rosen CB, Darwish Murad S, Heimbach JK, Nyberg SL, Nagorney DM, Gores GJ,. (2012) Neoadjuvant therapy and liver transplantation for hilar cholangiocarcinoma: is pretreatment pathological confirmation of diagnosis necessary? J Am Coll Surg 215: 31-38.
12. Rosen CB, Nagorney DM,. (1991) Cholangiocarcinoma complicating primary sclerosing cholangitis. Semin Liver Dis 11: 26-30.
13. Stieber AC, Marino IR, Iwatsuki S, Starzl TE,. (1989) Cholangiocarcinoma in sclerosing cholangitis. The role of liver transplantation. Int Surg 74: 1-3. (Pubitemid 19135307)
14. Khan SA, Davidson BR, Goldin R, Pereira SP, Rosenberg WM, Taylor-Robinson SD, et al. (2002) Guidelines for the diagnosis and treatment of cholangiocarcinoma: consensus document. Gut 51 (Suppl 6): VI1-VI9. (Pubitemid 35216840)
15. Rea DJ, Rosen CB, Nagorney DM, Heimbach JK, Gores GJ,. (2009) Transplantation for cholangiocarcinoma: when and for whom? Surg Oncol Clin N Am 18: 325-337. ix.
16. Rea DJ, Heimbach JK, Rosen CB, Haddock MG, Alberts SR, Kremers WK, et al. (2005) Liver transplantation with neoadjuvant chemoradiation is more effective than resection for hilar cholangiocarcinoma. Ann Surg 242: 451-458. discussion 8-61.
17. Rosen CB, Heimbach JK, Gores GJ,. (2008) Surgery for cholangiocarcinoma: the role of liver transplantation. HPB 10: 186-189. (Pubitemid 352016246)
18. Darwish Murad S, Kim WR, Harnois DM, Douglas DD, Burton J, Kulik LM, et al. (2012) Efficacy of neoadjuvant chemoradiation, followed by liver transplantation, for perihilar cholangiocarcinoma at 12 US Centers. Gastroenterology 143: 88-98. e3.
19. Meza-Junco J, Montano-Loza AJ, Ma M, Wong W, Sawyer MB, Bain VG,. (2010) Cholangiocarcinoma: has there been any progress? Can J Gastroenterol 24: 52-57.
20. Terrault NA, Roland ME, Schiano T, Dove L, Wong MT, Poordad F, et al. (2012) Outcomes of liver transplant recipients with hepatitis C and human immunodeficiency virus coinfection. Liver Transpl 18: 716-726.
21. Miro JM, Montejo M, Castells L, Rafecas A, Moreno S, Aguero F, et al. (2012) Outcome of HCV/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study. Am J Transplant 12: 1866-1876.
22. Gores GJ, Nagorney DM, Rosen CB,. (2007) Cholangiocarcinoma: is transplantation an option? For whom? J Hepatol 47: 455-459. (Pubitemid 47331754)
23. Deoliveira ML, Schulick RD, Nimura Y, Rosen C, Gores G, Neuhaus P, et al. (2011) New staging system and a registry for perihilar cholangiocarcinoma. Hepatology 53: 1363-1371.